Meeting
2020 ASCO Virtual Scientific Program
Systemic therapy for patients with breast cancer and one to three brain metastases (BM).
Authors
Zaid A Soomro
University of Texas MD Anderson Cancer Center, Houston, TX
Zaid A Soomro , Omar Alhalabi , Ryan Sun , Aya Albittar , Limin Hsu , Vicente Valero , Nuhad K. Ibrahim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Metastatic
Track
Breast Cancer
Sub Track
Other Breast Cancer Subtypes
Citation
J Clin Oncol 38: 2020 (suppl; abstr 1090)
DOI
10.1200/JCO.2020.38.15_suppl.1090
Abstract #
1090
Poster Bd #
175
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer and brain metastases: 3-year follow-up results from the phase 2 PERMEATE trial.
First Author: Min Yan
Poster
2022 ASCO Annual Meeting
Complications and severity of COVID-19 in patients with head and neck cancer (HNC): A COVID-19 and Cancer Consortium (CCC19) registry analysis.
First Author: Vidhya Karivedu
Poster
2021 ASCO Annual Meeting
Real-world outcomes of breast cancer patients with brain metastases treated with radiotherapy in Ontario: A population-based study.
First Author: Katarzyna Joanna Jerzak
Poster
2017 ASCO Annual Meeting
Outcomes from 735 patients with breast cancer brain metastases (BM) according to biological subtype, number of BMs, and systemic treatment after local therapy.
First Author: Anna Niwinska